Iraqi Board Dermatology study materials
Iraqi Board Dermatology study resources

Iraqi Board Dermatology: Systemic Disease and Skin

Iraqi Board Dermatology · Work through your exam, one topic at a time.

All guide sections

Systemic Disease and Skin

Domain 10 tests whether you connect skin signs to internal disease and drug timelines.

Cutaneous signs of systemic disease

  • Acanthosis nigricans reflects insulin resistance, but sudden widespread disease suggests gastrointestinal malignancy.
  • Paraneoplastic: dermatomyositis, acquired ichthyosis, Leser-Trelat sign, tripe palms.
  • Pyoderma gangrenosum (inflammatory bowel disease, myeloma), Sweet syndrome (malignancy, drugs), necrolytic migratory erythema (glucagonoma).
  • Diabetes: necrobiosis lipoidica and diabetic dermopathy. Thyroid: pretibial myxedema. Renal: calciphylaxis.

Drug eruptions

  • Morbilliform exanthem is commonest; the timeline after starting a drug is the key clue.
  • Stevens-Johnson syndrome and toxic epidermal necrolysis: mucosal erosions, epidermal detachment, positive Nikolsky; body surface area below 10%, 10-30%, above 30%; SCORTEN gives prognosis; stop the drug and give supportive care.
  • DRESS: fever, rash, eosinophilia, hepatitis, HHV-6 reactivation; RegiSCAR criteria.
  • AGEP: pustules with neutrophilia. Fixed drug eruption recurs at the same site.

Worked example

A 60-year-old on allopurinol for 3 weeks has fever, facial oedema, diffuse rash, eosinophilia and ALT 250. Diagnosis: DRESS. Reasoning: drug latency, eosinophilia and organ involvement; stop allopurinol, give systemic corticosteroids and monitor liver and thyroid.

Traps

Do not call every rash allergy without a timeline. Do not confuse erythema multiforme (targetoid, herpes-associated) with Stevens-Johnson syndrome. Do not miss mucosal involvement in a morbilliform eruption.